Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Aluminum hydroxide
Drug ID BADD_D02611
Description Aluminum hydroxide is an inorganic salt used as an antacid. It is a basic compound that acts by neutralizing hydrochloric acid in gastric secretions. Subsequent increases in pH may inhibit the action of pepsin. An increase in bicarbonate ions and prostaglandins may also confer cytoprotective effects.
Indications and Usage For relief of heartburn and acid indigestion.
Marketing Status approved; investigational
ATC Code A02AB02
DrugBank ID DB06723
KEGG ID D02416
MeSH ID D000536
PubChem ID 10176082
TTD Drug ID D0EQ6V
NDC Product Code 12784-148; 67417-245; 12784-147; 12784-350; 67417-238; 0536-0091; 12784-149; 12784-433; 12784-455; 67417-237; 51927-5167; 67417-219; 12784-137; 12784-199; 12784-438; 12784-429; 55603-671; 12784-146; 12784-427; 55603-211
UNII 5QB0T2IUN0
Synonyms Aluminum Hydroxide | Hydroxide, Aluminum | Hydrated Alumina | Alumina, Hydrated | Alugel | Algeldrate | Rocgel | Brasivil | Dialume | Nephrox | Pepsamer | Alhydrogel | Amphojel | Basalgel | Aldrox
Chemical Information
Molecular Formula AlH3O3
CAS Registry Number 21645-51-2
SMILES [OH-].[OH-].[OH-].[Al+3]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Asthenia08.01.01.001--Not Available
Back pain15.03.04.005--
Chills15.05.03.016; 08.01.09.001--
Chromaturia20.02.01.002--
Constipation07.02.02.001--
Cough22.02.03.001--
Crying19.04.02.002; 17.02.05.013; 12.02.11.001; 08.01.03.005--Not Available
Disorientation17.02.05.015; 19.13.01.002--Not Available
Dysphonia22.12.03.006; 19.19.03.002; 17.02.08.004--
Ear pain04.03.01.003--
Erythema23.03.06.001--Not Available
Eye swelling06.08.03.003--Not Available
Fatigue08.01.01.002--
Feeling hot08.01.09.009--Not Available
Headache17.14.01.001--
Injection site mass12.07.03.010; 08.02.03.009--Not Available
Injection site reaction08.02.03.014; 12.07.03.015--
Irritability19.04.02.013; 08.01.03.011--
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Local reaction08.01.03.012--Not Available
Malaise08.01.01.003--
Muscle spasms15.05.03.004--
Myalgia15.05.02.001--
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Pain08.01.08.004--
Pain in extremity15.03.04.010--
Pyrexia08.05.02.003--
The 1th Page    1 2    Next   Last    Total 2 Pages